Biomarkers predictive of survival and response to immune checkpoint inhibitors (ICI) in melanoma

Immunotherapy has revolutionized the treatment of melanoma. Targeting of the immune checkpoints cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 has led to improved survival in a subset of patients. Unfortunately, the use of immune checkpoint inhibitors is associated w...

Full description

Saved in:
Bibliographic Details
Published in:Am J Clin Dermatol
Main Authors: Rizk, Emanuelle M., Seffens, Angelina M., Trager, Megan H., Moore, Michael R., Geskin, Larisa J., Gartrell-Corrado, Robyn D., Wong, Winston, Saenger, Yvonne M.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994371/
https://ncbi.nlm.nih.gov/pubmed/31602560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00475-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items